AI & ChatGPT searches , social queries for SRX251

Search references for SRX251. Phrases containing SRX251

See searches and references containing SRX251!

AI searches containing SRX251

SRX251

  • SRX251

    • Pharmaceutical compound

    SRX251, or SRX-251, also known as API-251, is a selective vasopressin V1A receptor antagonist that is or was under development for the treatment of aggression

    SRX251

    SRX251

    SRX251

  • NTX-1472

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    NTX-1472

    NTX-1472

  • SRX246

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    SRX246

    SRX246

    SRX246

  • Lithium carbonate

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Lithium carbonate

    Lithium carbonate

    Lithium_carbonate

  • LIT-002

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    LIT-002

    LIT-002

    LIT-002

  • Vasopressin

    • Mammalian hormone released from the pituitary gland

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Vasopressin

    Vasopressin

    Vasopressin

  • Oxytocin

    • Peptide hormone and neuropeptide

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Oxytocin

    Oxytocin

    Oxytocin

  • Nelivaptan

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Nelivaptan

    Nelivaptan

    Nelivaptan

  • Desmopressin

    • Medication

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Desmopressin

    Desmopressin

    Desmopressin

  • Demeclocycline

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Demeclocycline

    Demeclocycline

    Demeclocycline

  • Carbetocin

    • Medication used for preventing postpartum bleeding

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Carbetocin

    Carbetocin

    Carbetocin

  • Tolvaptan

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Tolvaptan

    Tolvaptan

    Tolvaptan

  • List of investigational aggression drugs

    • (MAO-B) inhibitor KNX-101 – 15-lipoxygenase (15-LOX; ALOX15) inhibitor SRX251 – vasopressin V1A receptor antagonist – no recent development since 2007

    List of investigational aggression drugs

    List_of_investigational_aggression_drugs

  • PF-184563

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    PF-184563

    PF-184563

    PF-184563

  • Vasopressin receptor antagonist

    • Agent that interferes with action at the vasopressin receptors

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Vasopressin receptor antagonist

    Vasopressin_receptor_antagonist

  • Uterotonic

    • Medication causing uterine contraction

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Uterotonic

    Uterotonic

  • TGOT

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    TGOT

    TGOT

  • Oxytocin receptor agonist

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Oxytocin receptor agonist

    Oxytocin receptor agonist

    Oxytocin_receptor_agonist

  • LIT-001

    • Small-molecule oxytocin receptor agonist

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    LIT-001

    LIT-001

    LIT-001

  • Oxytocin (medication)

    • Medication made from the peptide oxytocin

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Oxytocin (medication)

    Oxytocin (medication)

    Oxytocin_(medication)

  • Terlipressin

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Terlipressin

    Terlipressin

    Terlipressin

  • Retosiban

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Retosiban

    Retosiban

    Retosiban

  • Vasopressin receptor 2

    • Protein-coding gene in the species Homo sapiens

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Vasopressin receptor 2

    Vasopressin receptor 2

    Vasopressin_receptor_2

  • Barusiban

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Barusiban

    Barusiban

    Barusiban

  • Cligosiban

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Cligosiban

    Cligosiban

    Cligosiban

  • Atosiban

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Atosiban

    Atosiban

    Atosiban

  • Neurophysin I

    • Cleavage product of the coding protein of OXT gene

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Neurophysin I

    Neurophysin_I

  • L-368,899

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    L-368,899

    L-368,899

    L-368,899

  • Vasotocin

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Vasotocin

    Vasotocin

    Vasotocin

  • Neurophysins

    • Carrier protein for oxytocin and vasopressin

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Neurophysins

    Neurophysins

  • Lixivaptan

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Lixivaptan

    Lixivaptan

    Lixivaptan

  • Serenic

    • Type of drug that reduces aggression

    Izenwasser S (eds.). "Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior". Pharmacology, Biochemistry, and

    Serenic

    Serenic

  • Ornipressin

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Ornipressin

    Ornipressin

    Ornipressin

  • CA7 (drug)

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    CA7 (drug)

    CA7 (drug)

    CA7_(drug)

  • TC OT 39

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    TC OT 39

    TC OT 39

    TC_OT_39

  • Vasopressin (medication)

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Vasopressin (medication)

    Vasopressin (medication)

    Vasopressin_(medication)

  • WAY-267464

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    WAY-267464

    WAY-267464

    WAY-267464

  • Conivaptan

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Conivaptan

    Conivaptan

    Conivaptan

  • Oxytocin receptor

    • Genes on human chromosome 3

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Oxytocin receptor

    Oxytocin receptor

    Oxytocin_receptor

  • Epelsiban

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Epelsiban

    Epelsiban

    Epelsiban

  • PF-06655075

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    PF-06655075

    PF-06655075

  • L-371,257

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    L-371,257

    L-371,257

    L-371,257

  • Selepressin

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Selepressin

    Selepressin

    Selepressin

  • Demoxytocin

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Demoxytocin

    Demoxytocin

    Demoxytocin

  • Brezivaptan

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Brezivaptan

    Brezivaptan

    Brezivaptan

  • NP-1031

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    NP-1031

    NP-1031

  • WJ0679

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    WJ0679

    WJ0679

    WJ0679

  • KNX-100

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    KNX-100

    KNX-100

    KNX-100

  • Merotocin

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Merotocin

    Merotocin

    Merotocin

  • Nolasiban

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Nolasiban

    Nolasiban

    Nolasiban

  • Balovaptan

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Balovaptan

    Balovaptan

    Balovaptan

  • Vasopressin receptor 1A

    • Protein-coding gene in the species Homo sapiens

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Vasopressin receptor 1A

    Vasopressin receptor 1A

    Vasopressin_receptor_1A

  • Lipo-oxytocin-1

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Lipo-oxytocin-1

    Lipo-oxytocin-1

    Lipo-oxytocin-1

  • OT-12

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    OT-12

    OT-12

  • Tocinoic acid

    • Oxytocin receptor antagonist

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Tocinoic acid

    Tocinoic acid

    Tocinoic_acid

  • Neurophysin II

    • Cleavage product of the arginine vasopressin gene

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Neurophysin II

    Neurophysin II

    Neurophysin_II

  • KNX-101

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    KNX-101

    KNX-101

  • RG7713

    • Vasopressin V1A receptor antagonist

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    RG7713

    RG7713

    RG7713

  • Felypressin

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Felypressin

    Felypressin

    Felypressin

  • Vasopressin receptor

    • G protein-coupled receptor

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Vasopressin receptor

    Vasopressin_receptor

  • Vasopressin receptor 1B

    • Protein-coding gene in the species Homo sapiens

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Vasopressin receptor 1B

    Vasopressin receptor 1B

    Vasopressin_receptor_1B

  • Relcovaptan

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Relcovaptan

    Relcovaptan

    Relcovaptan

  • NMRA-511

    • Pharmaceutical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    NMRA-511

    NMRA-511

  • Satavaptan

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Satavaptan

    Satavaptan

    Satavaptan

  • ABT-436

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    ABT-436

    ABT-436

  • Mozavaptan

    • Chemical compound

    LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471 V1B Agonists: d[Cha4]AVP DDAVP

    Mozavaptan

    Mozavaptan

    Mozavaptan

AI & ChatGPT searchs for online references containing SRX251

SRX251

AI search references containing SRX251

SRX251

AI search queries for Facebook and twitter posts, hashtags with SRX251

SRX251

Follow users with usernames @SRX251 or posting hashtags containing #SRX251

SRX251

Online names & meanings

AI search & ChatGPT queries for Facebook and twitter users, user names, hashtags with SRX251

SRX251

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing SRX251

SRX251

AI searchs for Acronyms & meanings containing SRX251

SRX251

AI searches, Indeed job searches and job offers containing SRX251

Other words and meanings similar to

SRX251

AI search in online dictionary sources & meanings containing SRX251

SRX251